The SAFE Strategy

The SAFE Strategy is an innovative public health approach designed to treat and prevent trachoma. Endorsed by the World Health Organization, the components of SAFE are:

Through the work of ITI, national governments, implementing partners, and a host of agencies (governmental and non-governmental) at the national and local levels, the implementation of the SAFE strategy has led to measurable results in the elimination of trachoma, and improved the quality of life for millions of people.

For example:

  • Morocco, one of the first countries to implement SAFE at the national level, became the first country to achieve its ultimate intervention goals in 2006.
  • The Gambia, Ghana and Vietnam are on track to reach their ultimate intervention goals.
  • ITI has expanded its support of the “A” component of the SAFE strategy to more than 20 countries in Africa and Asia.

As of 2014, Pfizer has donated more than 340 million Zithromax® treatments through ITI.

To date, Pfizer's donation of Zithromax® through the ITI has reached millions of people in 29 countries. ITI plans to be active in more than 42 countries by 2015.

Breaking the Cycle of Poverty

The impact of ITI’s efforts reaches far beyond the elimination of blinding trachoma. The SAFE strategy addresses broader poverty and development issues, resulting in improved quality of life for millions of people in some of the world’s poorest countries.

Reducing trachoma and blindness caused by trachoma breaks a cycle of poverty by preserving the ability of individuals to work and provide for their families, as well as increasing children’s school attendance.